Featured

  • May 11, 2023
  • North America
  • Healthcare

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication

ROSEMONT, ILLINOIS – May 4, 2023 – Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar Injectables, Inc. This manufactured, ready-to-use formulation is room-temperature stable and will be available in three commonly administered…

Read More

All Releases

Reset Filters

  • May 11, 2023
  • North America
  • Healthcare

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication

ROSEMONT, ILLINOIS – May 4, 2023 – Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar Injectables, Inc. This manufactured, ready-to-use formulation is room-temperature stable and will be available in three commonly administered …

Read More

  • November 3, 2022
  • North America
  • Business Services

H.I.G. Capital Completes Acquisition of Celerion

MIAMI – November 3, 2022 – H.I.G. Capital (“H.I.G.”), a leading global investment firm with $52 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of Celerion Holdings, Inc. (“Celerion” or …

Read More

  • September 13, 2022
  • North America

H.I.G. Capital Completes Recapitalization of Navitas Life Sciences

MIAMI – September 13, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences …

Read More

  • June 29, 2022
  • North America

Leiters Joins the End Drug Shortages Alliance

DENVER – June 29, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The …

Read More

  • June 9, 2022
  • North America

Memorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical Compounding Industry Leader

DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor …

Read More

  • April 28, 2022
  • North America

Nevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in a Prefilled Syringe

BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that …

Read More

  • April 15, 2022
  • North America

Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank

NEW YORK – April 15, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were …

Read More

  • March 8, 2022
  • Europe, North America

On Target Laboratories and Mauna Kea Technologies Announce a Novel Clinical Research and Product Development Collaboration

PARIS & BOSTON – March 8, 2022 – On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA, ‘Mauna Kea’) …

Read More

  • March 2, 2022
  • North America
  • Healthcare

H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe

STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-science investment affiliate, H.I.G. …

Read More

  • February 8, 2022
  • North America

Leiters Announces Facility Acquisition to Increase Capacity, Accommodate Growth and Expand Portfolio

DENVER – February 8, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of hospital and ophthalmology compounded sterile preparations announced today that it has completed the purchase of a new manufacturing facility in Buena, New Jersey. The 110,000 square …

Read More

Displaying 10 of 184 News Articles

×